Fluent agrees to sell Texas cannabis business to Legacy Therapeutics for $30 million

  • Fluent entered agreement to sell its Texas business to Legacy Therapeutics for USD 30 million.
  • Deal covers Cansortium Texas operations, including cultivation and manufacturing in Schulenburg, Texas, delivery business, and Houston retail operations.
  • Consideration includes USD 25 million payable at closing.
  • Additional payments of USD 2.5 million are due on first and second anniversaries of closing.
  • Proceeds are expected to be used primarily to repay part of Fluent’s existing senior secured debt.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fluent Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605011650PRIMZONEFULLFEED9711684) on May 01, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.